DAMGO drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| DAMGO | targets | OPRM1 | — | 2 |
Mentioned in (1)
Papers in which this entity is mentioned.
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| damgo | drug | 7 | 27 |
| [3h]-d-ala2, n-mephe4, gly-ol]-enkephalin | drug | — | — |
| d-ala2-mephe4-gly-ol5-enkephalin | drug | — | — |
| [d-ala2,n-mephe4,gly-ol5]-enkephalin | drug | — | — |
| [d-ala 2, n-mephe4, gly-ol]-enkephalin | drug | — | — |
| [d-ala2, n-mephe4, gly-ol]-enkephalin | drug | — | — |